135
Views
11
CrossRef citations to date
0
Altmetric
Letters

Serum amyloid A (SAA) treatment enhances the recovery of aggravated polymicrobial sepsis in mice, whereas blocking SAA’s invariant peptide results in early death

, , &
Pages 149-150 | Received 19 Jan 2017, Accepted 13 Feb 2017, Published online: 22 Apr 2017

References

  • Global Sepsis Alliance statement @2015. Available from: http://globalsepsisalliance.com/the-gsa/
  • Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol 2000;7:64–9
  • Linke RP. Monoclonal antibodies against amyloid fibril protein AA. Production, specificity, and use for immunohistochemical localization and classification of AA-type amyloidosis. J Histochem Cytochem 1984;32:322–8
  • Linke RP, Bock V, Valet G, Rothe G. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem Biophys Res Commun 1991;176:1100–5
  • Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, Müller M, Blander JM, et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell functions. J Exp Med 2010;207:1453–64

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.